Clinical trial
Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
NCT03634787 is registered in ClinicalTrials.gov with Vilnius University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
- Lead sponsor
- Vilnius University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 20, 2017
- Completion date
- December 30, 2021
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis